Extracorporeal membrane oxygenation for treatment of cardiac failure in adult patients
Why the study?
Does venoarterial ECMO support improve survival and allow successful weaning or bridging in adult patients with cardiogenic shock?
Population
45 adult patients with cardiogenic shock requiring temporary extracorporeal membrane oxygenation support…
Design
Cohort
Follow-up
In-hospital
Authors
Discussion
Loading...
Member takes
Implication
May support short-term survival in cardiogenic shock; leaves open optimal patient selection for prospective trials.
Structured PICO
Does venoarterial ECMO support improve survival and allow successful weaning or bridging in adult patients with cardiogenic shock?
P
Population
45 adult patients with cardiogenic shock requiring temporary extracorporeal membrane oxygenation (ECMO) support, including post-cardiotomy (n=31), post-transplantation (n=5), and decompensated heart failure (n=9).
I
Intervention
Venoarterial extracorporeal membrane oxygenation (ECMO) support (average duration 126.7 +/- 104.3 hours) implanted via femoral vessels, axillary artery, or right atrium and ascending aorta.
O
Outcome
In-hospital mortality and successful weaning/discharge from supporthard clinical
Venoarterial ECMO provides effective temporary cardiopulmonary support for adult patients in cardiogenic shock, achieving a 58% survival to discharge rate, though mortality remains high in those developing acute renal failure requiring CRRT.
Cite This Study
Luo et al. (2009) studied this question.